KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia

High-risk B-cell acute lymphoblastic leukemia (B-ALL) remains a therapeutic challenge despite advances in the use of tyrosine kinase inhibitors and chimeric-antigen-receptor engineered T cells. Lymphoblastic-leukemia precursors are highly sensitive to oxidative stress. KLF5 is a member of the Krüppe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cuiping, D'Alessandro, Angelo, Wellendorf, Ashley M., Mohmoud, Fatima, Serrano-Lopez, Juana, Perentesis, John P., Komurov, Kakajan, Alexe, Gabriela, Stegmaier, Kimberly, Whitsett, Jeffrey A., Grimes, H. Leighton, Cancelas, Jose A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049869/
https://www.ncbi.nlm.nih.gov/pubmed/30038712
http://dx.doi.org/10.18632/oncotarget.25667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049869/
https://www.ncbi.nlm.nih.gov/pubmed/30038712
http://dx.doi.org/10.18632/oncotarget.25667

Ejemplares similares